Insider Transactions in Q3 2021 at Kindred Biosciences, Inc. (KIN)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 27
2021
|
Park West Asset Management LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
6,000,002
-100.0%
|
-
|
|
Aug 27
2021
|
Raymond Townsend Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
24,928
-100.0%
|
$224,352
$9.25 P/Share
|
|
Aug 27
2021
|
Hangjun Zhan Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
64,306
-100.0%
|
$578,754
$9.25 P/Share
|
|
Aug 27
2021
|
Denise Bevers Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
145,835
-100.0%
|
$1,312,515
$9.25 P/Share
|
|
Aug 27
2021
|
Wendy Wee Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
78,613
-100.0%
|
$707,517
$9.25 P/Share
|
|
Aug 27
2021
|
Richard Chin Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
8,000
-100.0%
|
$72,000
$9.25 P/Share
|
|
Aug 27
2021
|
Richard Chin Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,709,271
-100.0%
|
$15,383,439
$9.25 P/Share
|
|
Aug 27
2021
|
Elanco Animal Health Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
45,508,938
+99.98%
|
$409,580,442
$9.25 P/Share
|
|
Aug 02
2021
|
Richard Chin Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,000
-2.54%
|
$360,000
$9.21 P/Share
|
|
Jul 22
2021
|
Richard Chin Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
320,000
-16.89%
|
-
|
|
Jul 02
2021
|
Richard Chin Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,000
-2.07%
|
$360,000
$9.18 P/Share
|